FAP and pancreatic adenocarcinoma: Given that heterogeneous and differential FAP+ CAFs in PAAD tumors may be involved to varying degrees in stromal variation, immunosuppression, and differential responses to potential immunotherapy, further experimental studies are necessary to clarify the potential causal inference.